Company profile for Romark

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Romark is a vertically-integrated, research-based pharmaceutical company focused on the discovery, development and delivery of innovative new medicines, primarily in the field of infectious diseases. Romark has operations in the United States, Puerto Rico and Europe, and it conducts research and development and commercializes its products globally. Romark is a leader in developing new drugs for treating a broad range of sea...
Romark is a vertically-integrated, research-based pharmaceutical company focused on the discovery, development and delivery of innovative new medicines, primarily in the field of infectious diseases. Romark has operations in the United States, Puerto Rico and Europe, and it conducts research and development and commercializes its products globally. Romark is a leader in developing new drugs for treating a broad range of seasonal, emerging and drug-resistant viral respiratory illnesses.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3000 Bayport Drive, Suite 200 Tampa, Florida 33607
Telephone
Telephone
(813) 282-8544
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/manufacturing/romark-snares-fda-nod-to-produce-diarrhea-med-alinia-at-puerto-rico-plant

F. Kansteiner FIERCEPHARMA
28 Aug 2020
FDA Approves Romark Facility in Puerto Rico
FDA Approves Romark Facility in Puerto Rico

24 Aug 2020

// CONTRACTPHARMA

https://www.contractpharma.com/contents/view_breaking-news/2020-08-24/fda-approves-romark-facility-in-puerto-rico/

CONTRACTPHARMA
24 Aug 2020

https://www.prnewswire.com/news-releases/romark-initiates-phase-3-clinical-trials-of-nt-300-for-covid-19-301047259.html

PR NEWSWIRE
27 Apr 2020

https://www.prnewswire.com/news-releases/romark-initiates-phase-3-clinical-trials-of-nt-300-for-covid-19-301047259.html

PR NEWSWIRE
27 Apr 2020

http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0983-2015&w=05132015&lang=eng

FDA
13 May 2015

ABOUT THIS PAGE

Contact Romark and get a quotation

Romark is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Nitazoxanide bulk with DMF offered by Romark

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty